Dr. Ameera Patel, CEO of TidalSense
Name: Dr. Ameera Patel
Position: Chief Executive Officer
Company: TidalSense
Location: Cambridge, UK
LinkedIn Profile: [Dr. Ameera Patel](https://www.linkedin.com/in/ameera-patel)
Twitter Profile: [Ameera Patel (@ameeraxpatel)](https://twitter.com/ameeraxpatel)
Professional Background
Dr. Ameera Patel is the CEO of TidalSense, a pioneering respiratory technology company. She holds both an MD and a PhD in applied mathematics, blending healthcare expertise with rigorous analytical skills. Dr. Patel has a background working within the NHS and has experience in the tech industry through a prior engagement with Microsoft.
Company Overview: TidalSense
Founded: 2013
Headquarters: The Vinery, 15a Vinery Road, Cambridge, CB1 3DN, UK
Primary Focus: Innovation in respiratory diagnostics through hardware and AI-driven software solutions.
Mission Statement: TidalSense aims to deliver faster, more precise, and more effective diagnosis and management of respiratory conditions, pushing towards preventative medicine through early diagnosis and personalized intervention.
Key Innovations and Products
- N-Tidal™: A patented sensor technology that captures and analyzes respiratory function.
- AI Diagnostic Models: Trained on millions of patient breaths for accurate and early diagnosis of COPD and asthma.
N-Tidal Diagnose: This flagship product uses AI to provide on-the-spot diagnoses for respiratory conditions, eliminating the need for extended, repeated clinical visits.
Leadership and Team
- Dr. Julian Carter, PhD: Director of Engineering, Founder
- Mark Gleeson, MBA: Commercial Director
- Christian Faires, CGMA ACMA: Chief Financial Officer
Board of Directors
- Natalie Douglas: Chairperson
- Dr. Ameera Patel, MD PhD: Chief Executive Officer
- Tim Rea: Partner at BGF
- Matt Pierce: Partner at Downing LLP
- Jeremy Curnock Cook: Independent Director
Strategic Partnerships and Collaborations
TidalSense works with various stakeholders, including healthcare providers like the NHS and pharmaceutical companies, to enhance respiratory care pathways and support new medicines development.
Recent Achievements and Investments
- 2013-2017: Developed and refined the N-Tidal hardware and sensor technology.
- Recent Investment: Secured £7.5 million led by BGF and Downing to propel AI diagnostic solutions and commercialize their technology.
- Public Funding: Garnered £4.5 million in public grants from Innovate UK, NIHR, and SBRI for early-stage development and validation.
Market Impact and Unmet Needs
Respiratory Condition Challenge: COPD and asthma diagnosis typically rely on spirometry, a suboptimal and outdated technology. TidalSense’s N-Tidal Diagnose offers a more patient-friendly, efficient, and accurate alternative.
Market Penetration:
- Addressing the global rise in respiratory diseases (affecting 10% of the population).
- Targeting early and accurate diagnosis to reduce late-stage healthcare costs and improve patient outcomes.
Company Vision and Future Directions
TidalSense plans to expand its diagnostics business beyond the UK. They are developing new AI algorithms to enhance diagnostic precision and predictions related to treatment efficacy and clinical risk.
Personal Insights from Dr. Ameera Patel
Dr. Patel emphasizes the importance of culture within her team. TidalSense promotes a non-hierarchical, respect-driven environment that values ideas and personal well-being. Dr. Patel relies on her team's energy and camaraderie to foster a productive and engaging workplace.
Personal Philosophy: Dr. Patel highlights balancing work with personal health, encouraging self-care among her team. She sets an example by participating in activities like yoga and bouldering to manage stress and maintain focus.
Address and Additional Links
Registered Address:
The Vinery
15a Vinery Road
Cambridge, CB1 3DN, UK
[Open in Maps](https://tidalsense.com/team/)
Quick Links:
[LinkedIn](https://uk.linkedin.com/company/tidalsense)
[Twitter](https://twitter.com/ameeraxpatel)
[Facebook](https://www.facebook.com/TidalSenseUK)
Data collected from various verified sources
